Harrow, Inc. (HROW) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to HARO's first quarter 2026 earnings conference call. My name is Michelle and I will be your operator for today's call. At this time all participants are in a listen only mode. Later we will conduct a question and answer session. As a reminder this conference is being recorded. I would now like to turn the call over to to Mike Biaga, Vice President of Investor Relations and Communications for HARO. Please go ahead. Thank you, operator. Good morning, and welcome to HARO's first quarter 2026 earnings conference call. My name is Mike Biaga, Vice President of Investor Relations and Communications, and I'm excited to be introducing today's call. The company's remarks may include forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HARO's control, including risks and uncertainties described from time to time in its SEC filings, such as the risks and uncertainties related to the company's ability to make commercially available its FDA-approved products and compounded formulations and technologies and FDA approval of certain drug candidates in a timely manner or at all. For a list and description of those risks and uncertainties, please see the risk factor section of the company's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Harold's results may differ materially from those projected. Harold disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate ...